Global Data Intelligence Center
구분 보고서 (영문) 업로드 날짜
제약/바이오/
임상시험
COVID-19 Pandemic Accelerated Digital Transformation Progress 12-15-2023
Thematic Intelligence: The State of the Biopharmaceutical Industry 2024 12-18-2023
Weight Regain and Cardiometabolic Effects After Withdrawal of GLP-1R Agonists 12-18-2023
Dual Orexin Receptor Antagonists to Drive Insomnia Market Across 7MM to $4.1 Billion in 2032 12-18-2023
Eli Lilly's Mounjaro Set to Throw its Weight Around in Obesity Market 12-20-2023
Emerging Markets Contract Service Agreements – Q4 2023 12-21-2023
BMS’s Opdualag Faces Discontinuation, May Threaten Future of LAG- 3 Inhibitors in CRC 12-21-2023
Global AI trends in Pharmaceutical Manufacturing 12-22-2023
Bio/Pharmaceutical Outsourcing Report 12-22-2023
Contract Manufacturing: Opportunities and Threats – December 2023 12-22-2023
질환별 The Opportunities Arising from  the Unmet Needs in the Bronchiectasis Disease Landscape 12-14-2023
Gaucher Disease: Opportunity Assessment and Forecast 12-15-2023
Insomnia: Opportunity Assessment and Forecast 12-18-2023
Rheumatoid Arthritis: Competitive Landscape 12-21-2023
Gout: Opportunity Assessment and Forecast 12-22-2023
Age-Related Macular Degeneration: Seven-Market Drug Forecast and Market Analysis - Update 12-22-2023
컨퍼런스/
심포지엄/학회
ASH 2023: Syndax’s Revumenib Shows Impressive Results in R/R KMT2A-Rearranged Acute Leukemia 12-16-2023
Seagen Seeks New Approval for Tukysa in HER2+ Breast Cancer 12-18-2023
ASH 2023: Venclexta’s Addition to Imbruvica Confers PFS Advantage in R/R Mantle Cell Lymphoma 12-22-2023
ASH 2023: Miltenyi Biomedicine’s MB-CART 19.1 Enters the Race to Tackle Autoimmunity 12-27-2023

+ Recent posts